Fighting cancer is hard enough. Everyone deserves to heal in a clean, peaceful space. How one Crothall team is bringing comfort and control to patients in treatment When you’re in the middle of treatment for gynecologic cancer, even simple things like cleaning your home or apartment can feel impossible. “Because I was mentally foggy from…
Successful healthcare innovators harness behavioral science to achieve adoption and behavior change. The post Nudges, Not Information, For Engagement And Adoption appeared first on MedCity News.
As trends around expanded decision-making ecosystems, consumer empowerment, data and intelligence, and economic uncertainty become everyday realities, the need for medical device companies to rethink and expand their business models becomes more urgent. The post From Products to Services: How Medical Device Companies Miss $100M+ Opportunities appeared first on MedCity News.
As trends around expanded decision-making ecosystems, consumer empowerment, data and intelligence, and economic uncertainty become everyday realities, the need for medical device companies to rethink and expand their business models becomes more urgent. The post From Products to Services: How Medical Device Companies Miss $100M+ Opportunities appeared first on MedCity News.
[Sponsored] Greenway Health blends smart technology with human expertise to elevate revenue cycle. The post RCM Outsourcing: Balancing Human Expertise & Smart Technology appeared first on MedCity News.
[Sponsored] In an interview, Abarca President and COO Adriana Ramirez shared why the future of healthcare must prioritize the human experience, powered by technology. The post Pharmacy as the Front Line of the Consumer Experience Revolution appeared first on MedCity News.
AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data. The post AI Hallucinations: What Are They and Are They Always Bad? appeared first on MedCity News.
Pfizer is acquiring Metsera and its pipeline of obesity medications that could offer dosing and tolerability advantages for patients as well as a manufacturing edge for the pharma giant. Key data Phase 2 readouts for Metsera’s lead GLP-1 drug candidate are expected in 2026. The post Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major…
Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient. The post Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts appeared first on MedCity News.
With employee anxiety at an all-time high, reducing fear and stress is increasingly important to organizational performance. While leaders cannot control external events, they can help mitigate their impacts on their organizations and people. The post Treating Uncertainty: How Successful Pharma Leaders Can Protect Employee Wellbeing and the Bottom Line appeared first on MedCity News.